Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma patients

HORIZON: Melflufen in high risk relapsed refractory multiple myeloma patients with extramedullary disease

Iberdomide in combination with dexamethasone for multiple myeloma

First results of the GMMG-CONCEPT trial for multiple myeloma

What is the role of autologous stem cell transplant in multiple myeloma?

Once-weekly carfilzomib combined with lenalidomide and dexamethasone for multiple myeloma

PLEIADES: Daratumumab combinations for multiple myeloma

Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multiple myeloma

Treatment options for high risk relapsed/refractory multiple myeloma

BCMA: A new biomarker for multiple myeloma

ICARIA: Isatuximab, pomalidomide and dexamethasone in relapsed/refractory multiple myeloma

BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed/refractory multiple myeloma